SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-085615
Filing Date
2020-07-22
Accepted
2020-07-22 16:03:53
Documents
1
Period of Report
2020-06-29

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4927
  Complete submission text file 0001104659-20-085615.txt   7003
Mailing Address C/O SOFINNOVA PARTNERS 17 RUE DE SURENE PARIS XX 75008
Business Address C/O SOFINNOVA PARTNERS 17 RUE DE SURENE PARIS XX 75008 33 1 53 054100
SOFINNOVA CAPITAL VI FCPR (Reporting) CIK: 0001441261 (see all company filings)

State of Incorp.: XX
Type: 4 | Act: 34 | File No.: 001-38869 | Film No.: 201041549

Mailing Address 17 RUE DE SERENE PARIS I0 75008
Business Address 17 RUE DE SERENE PARIS I0 75008 33 1 53 05 41 13
Sofinnova Partners SAS (Reporting) CIK: 0001574139 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38869 | Film No.: 201041550

Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Issuer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations